Mid‐term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract

Abstract

A multi-center clinical trial was completed successfully with planned Pulsta valve implantation and demonstrated good mid-term effectiveness without device-related serious adverse events.